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icking Plaques That Pop . . .*
agat Narula, MD, PHD, FACC,†
loke V. Finn, MD,‡
nthony N. DeMaria, MD, MACC§
rvine and San Diego, California; and
oston, Massachusetts
n the U.S. alone, over 13 million individuals suffer from
oronary artery disease. Of these, 1.1 million patients
resent with acute myocardial infarction (AMI) every year
nd 400,000 succumb to the episode (1). In addition, about
50,000 new cases of unstable angina are diagnosed annu-
lly and 450,000 individuals experience sudden death as the
rst manifestation of the atherosclerotic process. Rupture of
n atherosclerotic plaque is responsible for up to 75% of
cute coronary episodes (2). Clinically, we have been unable
o identify the culprit plaques before rupture, and interven-
ion has always focused on management only after rupture
as produced an acute coronary event. This reactive strategy
oes little to prevent future events. Although multiple
irculating markers may help identify patients at higher risk
f acute coronary syndromes (3), it may be equally impor-
ant to identify coronary lesions susceptible to rupture with
he expectation that appropriate time-sensitive preventive
trategies will eventually be developed.
See pages 1946, 1954, and 1961
HARACTERISTICS OF VULNERABLE PLAQUE
istopathologic characteristics of ruptured plaques are well
efined (4) (Table 1) and, except for a fibrous cap which is
ntact, it is reasonable to assume that vulnerable plaques
xhibit similar features. Knowledge of such histopathologic
haracteristics should allow development of appropriate
maging techniques (5) to detect these lesions. The dis-
upted plaques have significantly attenuated fibrous caps,
hich almost always demonstrate intense macrophage in-
ltration. The thickness of the cap near the plaque rupture
ite has been reported to be 23 19 m and plaques with
aps 2 standard deviations above the mean (64 ) are
resumed to be vulnerable to rupture (6). Accordingly,
ulnerable plaques are termed “thin cap fibroatheroma”
TCFA). The attenuation of the fibrous cap is directly
elated to the extent of macrophage infiltration (4). The site
*Editorials published in the Journal of the American College of Cardiology reflect the
iews of the authors and do not necessarily represent the views of JACC or the
merican College of Cardiology.
From the †University of California Irvine School of Medicine, Irvine, California;
Massachusetts General Hospital, Boston, Massachusetts; and §University ofh
alifornia San Diego School of Medicine, San Diego, California. Supported by
IH/NHLBI RO1 HL 68657-01.f minimum thickness along the longitudinal or circumfer-
ntial course of the plaque is believed to be prone to rupture,
nd this site may not necessarily correspond to the shoulders
r summit of the plaque.
Although it is a common knowledge that the plaques
ndergoing rupture might not be critically occlusive, the
athologic characterization of vulnerable plaques and rup-
ured plaques (disrupted and healed ruptures) reveals that
hey need to mature to sizable extent before disruption (4,7).
wo-thirds of TCFA are 50% and one-quarter are 75%
ross-sectionally stenotic, whereas three-quarter ruptures
re 50% and one-half are 75% stenotic; 50% cross
ectional narrowing is observed in only 40% TCFA and 20%
n ruptures (7). It is therefore reasonable to presume that
etection of sufficiently large and thin-capped plaques
ould be possible by morphology-based imaging tech-
iques, such as intravascular ultrasound (IVUS).
The necrotic core in a given plaque is independent of
uminal narrowing and needs to exceed a critical threshold
o convey vulnerability. It occupies more than 25% of the
laque area in at least two-thirds of disrupted lesions (2,6).
he necrotic core in ruptured plaques and TCFA varies
rom 2 to 22 mm in length and demonstrates 60°
ircumferential involvement of the vessel. Such dimensions
ay offer an adequate target to the imaging strategies.
acrophage infiltration is intimately linked to the evolution
f necrotic core. During the process of subintimal migra-
ion, uninhibited ingestion of lipids converts macrophages
nto foam cells. Cholesterol esters and free cholesterol pack
he foam cells and eventually lead to their annihilation;
ying foam cells contribute to the enlargement of necrotic
ore. Progression from non-disrupted to disrupted lesion is
ssociated with an increase in ratio of free-to-esterified
holesterol (8) which may result from intraplaque hemor-
hage and red blood cell (RBC) deposition in the core area.
he cholesterol content of the erythrocyte membrane con-
titutes 40% of its weight; it is elevated in hypercholester-
lemia and decreases with statin treatment (9). The extent
f iron deposits in the plaque and the reactivity to glyco-
horin (a protein specific to the RBC membrane) corre-
pond to the size of the necrotic core. Changes in these
ariables parallel an increase in macrophage density, sug-
esting that hemorrhage may serve as an inflammatory
timulus (8). Intraplaque hemorrhage is believed to occur
rom the disruption of thin-walled microvessels that are
ined by a discontinuous endothelium without supporting
mooth muscle cell (SMC) (10). These microvessels repre-
ent a part of neoangiogenesis within the plaque confines
nd are associated with extensive vascular proliferation
round the adventitial vascular layer.
Plaque burden usually does not compromise lumen size
nless 40% or greater cross-sectional luminal narrowing has
ccurred, causing compensatory enlargement or remodeling
f the entire vessel (11,12). In particular, lesions with
emorrhage, large necrotic cores, and macrophage inflam-
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June 21, 2005:1970–3 Editorial Commentation are more likely to demonstrate vascular remodeling.
onversely, with nonrupture-related acute coronary events,
uch as those resulting from plaque erosion, plaques dem-
nstrate arterial shrinkage. The extent of arterial remodeling
s closely associated with the expression of activated metal-
oproteinases (13). The expansile growth of vessel ensures
hat vulnerable plaques are sizable and enhances their ability
o be imaged.
More than one-half of TCFA show either an absence or
nly speckled calcification, and the other half demonstrate a
arge variation in the degree of calcification (5), which is
ependent on patient age. From the pathologic standpoint,
oronary calcification correlates with the magnitude of
laque burden, but does not offer further association with
laque vulnerability. Based on the available information, it is
nlikely that a measure of calcification alone would allow
ssessment of plaque vulnerability.
NCIDENCE AND DISTRIBUTION OF TCFA
n patients dying of an AMI, the mean number of TCFA
ould be as high as 2.5 in men and 1.5 in women (3,7). In
ontrast, the incidence of TCFA in patients dying suddenly
s a little over one per heart and similar in both genders. The
ajority of TCFA occur predominantly in the proximal
ortion of the three major coronary arteries, and about
ne-half arise in the mid-portion of these arteries; they are
nly infrequently seen in the distal coronary circulation.
ecause the vulnerable plaques are not abundant and are
ften located proximally in major arteries, an effort to detect
ulnerable plaques is justified.
VUS FOR THE DETECTION OF VULNERABLE PLAQUES
ross sectional IVUS images of normal coronary arteries
emonstrate a sharp endothelial border, thin, clear echolu-
ent media, and dense adventitial layer (14). When intimal
hickening occurs during development of atherosclerotic
laques (11), signal free zones represent lipid accumulations,
oft echoes correspond to SMCs, fibrosis or collagen depo-
ition, and bright intensity indicates calcification (15,16).
urther, rupture or ulceration of lesions can often be
etected in culprit vessels (17). An IVUS interrogation of all
hree epicardial vessels in more than 200 patients (18)
able 1. Pathologic Characteristics of Ruptured Plaques
laque morphology
Large necrotic core
25% of plaque area
Vessel remodeling, 1 IEL
Plaque size, 50% occlusion in 4/5th
Neovascularization
Intraplaque hemorrhage
hin fibrous cap (65 )
oam cells in fibrous cap
Apoptosis, 40%
Increased MMP expression
EL  internal elastic lamina; MMP  matrix metalloproteinases.losely concurred with the pathologic literature that plaque mupture of the infarct-related vessel occurred in two-thirds
f patients presenting with AMI; of these, one-fifth of the
atients had evidence of multiple ruptures. The plaques
nderlying culprit lesions were hypoechoic, eccentric, and
ositively remodeled. It is therefore expected that vulnerable
laques would demonstrate similar findings. Such presump-
ion has been vindicated by serial observations in a two-year
ollow-up of 100-plus patients (19). The lesions that devel-
ped into an acute coronary event were characteristically
arge and contained relatively shallow but prominent
cholucent zones. These features support the concept that
ulnerable plaques are generally not trivial, have a large
ecrotic core and thin fibrous covers, and demonstrate
utward remodeling at the site of culprit lesions.
UPPLEMENTING ULTRASONIC STRATEGIES
OR THE DETECTION OF VULNERABLE PLAQUES
everal modifications of ultrasonic techniques have allowed
mproved characterization of vulnerable plaques. For in-
tance, palpography (or elastography) assesses local defor-
ation of the fibrous cap tissue caused by the application of
ntraluminal pressure on the plaque surface (20,21). This
echnique can demonstrate significant differences between
brous and fatty tissue in autopsied coronary and femoral
rteries. Clinical studies have revealed high strain (1% to
%) in non-calcified and low strain (0% to 0.2%) values in
alcified areas of plaque. It is expected that high strain or
ulnerable regions will be better characterized with the
evelopment of three-dimensional elastography for the full
ength interrogation of a coronary artery.
Similarly, contrast echocardiography has been used to
valuate plaque vulnerability by IVUS (22). Since vulnerable
laques have extensive adventitial network of vasa vasorum
nd intraplaque neoangiogenesis, it has been presumed that
ncreased contrast intensity should indicate plaque vulnera-
ility. Further, negatively-charged microbubbles may tran-
iently attach to positively charged endothelium (of the
eovessels) to enhance their residence time and detectability
23). The increased porousness of the neoangiogenic vessels,
hich allows constant RBC leakage, may (although un-
ested) allow similar exit for microbubbles, which might
hen be phagocytosed by core macrophages to render them
chogenic (24). Such detection can be further enhanced by
mparting targeting specificity to microbubbles directed at
he novel receptors expressed on macrophages. In one such
xploitation of shell properties in an experimental model of
therosclerosis, phosphatidylserine was incorporated in the
iposome contrast agent to target the ubiquitously expressed
hosphatidylserine receptors of macrophages (25).
Two studies published in this issue of the Journal (26,27),
ffered refined analysis of IVUS data s for quantitative tissue
haracterization of plaque composition. Whereas Kawasaki
t al. (26) applied three-dimensional IVUS with integrated
olor-coded backscatter maps, Murashighe et al. (27) used a
athematical model for wavelet analysis of radiofrequency
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Editorial Comment June 21, 2005:1970–3VUS signals. These studies suggest that identification of
ipid-rich plaques from fibrous lesions may become clinically
easible. The former study evaluated the interval change in
therosclerotic lesion composition in response to treatment
ith statins or placebo, and demonstrated the feasibility of
etection of reduction in lipid volume and concomitant
ncrease in fibrous (and mixed) lesion volume in response to
tatins even before regression in geometric parameters
ecame apparent (26). The latter study (27) accurately
ifferentiated lipid-rich from fibrotic plaques that were
istologically verified in tissue specimens from necropsy or
irectional atherectomy.
UO VADIS VULNERABLE PLAQUE IMAGING
lthough detection of various morphologic features of
ulnerable plaque should become possible with IVUS tech-
iques, it will be reasonable to propose that simultaneous
fforts are invested in development of strategies that define
acrophage infiltration of fibrous caps. For IVUS to be-
ome capable of such identification, it will be necessary to
efine targeted imaging with microbubbles (28). It may also
e possible to superimpose functional imaging strategies
nto morphology-based techniques. The functional imaging
an be performed by radionuclide agents, such as F-18 FDG
29) or Tc-99m-labeled Annexin-A5 which target macro-
hage infiltration (30,31). Intravascular beta detectors are
ow being investigated to provide estimates of macrophage
nfiltration within the atherosclerotic lesions (32).
Another novel attempt employing intravascular magnetic
esonance imaging (MRI) is presented in this issue of the
ournal (33). Schniderman et al. (33) used a self-contained
RI probe integrated within the tip of a coronary catheter
hat provided cross-sectional images with a field of view of
50 m in depth and lateral resolution of 60°. Intravascular
RI was able to correctly identify shallow lipid cores,
redominantly fibrous lesions and interestingly foam cell
ich fibrous caps. Although the need to identify vulnerable
laque (beyond detecting the vulnerable patient) has not yet
ound universal acceptance, we believe that it will constitute
ne of the most important developments in our fight against
cute coronary events.
eprint requests and correspondence: Dr. Jagat Narula, UCI
edical Center, 101 The City Drive, Building 53, Rt. 81, Orange,
alifornia 92868-4080. Email: narula@uci.edu.
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